NCT01415102 A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372. Status COMPLETED Phase PHASE1
NCT01414257 Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A
NCT01411228 A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease Status COMPLETED Phase PHASE3
NCT01411215 A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department Status TERMINATED Phase N/A
NCT01408355 A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose. Status COMPLETED Phase PHASE1
NCT01407016 A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects Status COMPLETED Phase PHASE1
NCT01405196 Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT01405170 A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions Status WITHDRAWN Phase PHASE1
NCT01405157 A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions Status WITHDRAWN Phase PHASE1
NCT01405131 A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Status WITHDRAWN Phase PHASE1
NCT01405118 Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01404104 Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase NA
NCT01402817 Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas Status TERMINATED Phase PHASE2
NCT01401023 Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD) Status COMPLETED Phase NA
NCT01399840 Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies Status COMPLETED Phase PHASE1
NCT01399788 A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults Status COMPLETED Phase PHASE1
NCT01397006 Fibromyalgia of Less Than One Year Duration. Study of Pregabalin Status WITHDRAWN Phase PHASE4
NCT01396434 Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos Status COMPLETED Phase N/A
NCT01396408 A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE2